Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says
With two vaccines approved but challenging logistics and a patchy supply chain slowing down the government's vaccination efforts, it is easy to understand this article's practical thinking!
Abstract Written By:
Get updates from Caring Support
We'll keep you updated on all new application updates and features!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.